Relationship between IL-8 circulating levels and TLR2 hepatic expression in women with morbid obesity and nonalcoholic steatohepatitis

T Auguet, L Bertran, J Binetti, C Aguilar… - International journal of …, 2020 - mdpi.com
The progression of nonalcoholic fatty liver disease (NAFLD) to nonalcoholic steatohepatitis
(NASH) is linked to systemic inflammation. Currently, two of the aspects that need further …

Role of serum toll‐like receptors 2 and 4 in non‐alcoholic steatohepatitis and liver fibrosis

M Cengiz, S Ozenirler, S Elbeg - Journal of gastroenterology …, 2015 - Wiley Online Library
Abstract Background and Aim Non‐alcoholic fatty liver disease is a common cause of
chronic liver disease, including non‐alcoholic steatohepatitis (NASH). Our aim was to …

Serum cytokine and soluble cytokine receptor levels in patients with non‐alcoholic steatohepatitis

S Abiru, K Migita, Y Maeda, M Daikoku, M Ito… - Liver …, 2006 - Wiley Online Library
Background: Although the pathogenesis of non‐alcoholic steatohepatitis (NASH) remains
poorly understood, proinflammatory cytokines seem to play an important role in the process …

Hepatic TLR4 signaling in obese NAFLD

T Sharifnia, J Antoun, TGC Verriere… - American Journal …, 2015 - journals.physiology.org
Nonalcoholic fatty liver disease occurs frequently in the setting of metabolic syndrome, but
the factors leading to nonalcoholic steatohepatitis (NASH) are not fully understood. This …

Cytokines Genotype‐Phenotype Correlation in Nonalcoholic Steatohepatitis

IC Bocsan, MV Milaciu, RM Pop… - Oxidative medicine …, 2017 - Wiley Online Library
NASH consists in lipid accumulation in hepatocytes that trigger oxidative stress, secretion of
proinflammatory cytokines leading to steatohepatitis (NASH). The study aimed to investigate …

Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans

J Pihlajamäki, T Kuulasmaa, D Kaminska… - Journal of …, 2012 - Elsevier
BACKGROUND & AIMS: Mechanisms leading to non-alcoholic steatohepatitis (NASH) have
remained unclear, and non-invasive diagnosis of NASH is challenging. In this study, we …

Role of cytokines in the pathogenesis of non-alcoholic fatty liver disease

SK Das, V Balakrishnan - Indian Journal of Clinical Biochemistry, 2011 - Springer
A number of factors are linked with non-alcoholic fatty liver diseases (NAFLD), a condition
that ranges from clinically benign fatty liver to its more severe form, non alcoholic …

Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in …

RM Hashem, MF Mahmoud… - European journal of …, 2008 - journals.lww.com
Objectives Fatty liver disease is commonly associated with diabetes mellitus (DM). Insulin
resistance (IR) as an investigative biomarker is only concerned with fatty liver that results …

[PDF][PDF] A novel pathophysiological-based panel of biomarkers for the diagnosis of nonalcoholic steatohepatitis

M Grigorescu, D Crisan, C Radu, MD Grigorescu… - J Physiol …, 2012 - academia.edu
Non-invasive biochemical markers are useful to distinguish between nonalcoholic
steatohepatitis (NASH) and simple steatosis. The aim of this study was to test the diagnostic …

Circulating levels of pro-inflammatory cytokines in patients with nonalcoholic fatty liver disease and non-alcoholic steatohepatitis

A Hadinia, AH Doustimotlagh, HR Goodarzi… - Iranian Journal of …, 2019 - iji.sums.ac.ir
Background: Pro-inflammatory cytokines are associated with systemic inflammatory
responses. Objective: To investigate the levels of pro-inflammatory cytokines (IL-1b, IL-6 …